Evidence map›Paper›PMID 23270367›Full record

ArticleBMC medical genomics2012

Mutation screen in the GWAS derived obesity gene SH2B1 including functional analyses of detected variants.

Anna-Lena Volckmar, Florian Bolze, Ivonne Jarick, Nadja Knoll, André Scherag, Thomas Reinehr, Thomas Illig, Harald Grallert, Heinz-Erich Wichmann, Susanna Wiegand and 8 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Association of theNutrients · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 2 countries.

Anna-Lena VolckmarDepartment of Child and Adolescent Psychiatry, University Duisburg-Essen, Virchowstr, 171, D 45147, Essen, Germany.
Florian Bolze
Ivonne Jarick
Nadja Knoll
André Scherag
Thomas Reinehr
Thomas Illig
Harald Grallert
Heinz-Erich Wichmann
Susanna Wiegand
Heike Biebermann
Heiko Krude
Pamela Fischer-Posovszky
Winfried Rief
Martin Wabitsch
Martin Klingenspor
Johannes Hebebrand
Anke Hinney
University of Duisburg-Essen · DECharité - Universitätsmedizin Berlin · DEHelmholtz Zentrum München · DEPhilipps University of Marburg · DEUniversität Ulm · DEFresenius (Germany) · DEMedizinische Hochschule Hannover · DENutrition Sciences (Belgium) · BEWitten/Herdecke University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe SH2B1 gene (Src-homology 2B adaptor protein 1 gene) is a solid candidate gene for obesity. Large scale GWAS studies depicted markers in the vicinity of the gene; animal models suggest a potential relevance for human body weight regulation.

methodsWe performed a mutation screen for variants in the SH2B1 coding sequence in 95 extremely obese children and adolescents. Detected variants were genotyped in independent childhood and adult study groups (up to 11,406 obese or overweight individuals and 4,568 controls). Functional implications on STAT3 mediated leptin signalling of the detected variants were analyzed in vitro.

resultsWe identified two new rare mutations and five known SNPs (rs147094247, rs7498665, rs60604881, rs62037368 and rs62037369) in SH2B1. Mutation g.9483C/T leads to a non-synonymous, non-conservative exchange in the beta (βThr656Ile) and gamma (γPro674Ser) splice variants of SH2B1. It was additionally detected in two of 11,206 (extremely) obese or overweight children, adolescents and adults, but not in 4,506 population-based normal-weight or lean controls. The non-coding mutation g.10182C/A at the 3' end of SH2B1 was only detected in three obese individuals. For the non-synonymous SNP rs7498665 (Thr484Ala) we observed nominal over-transmission of the previously described risk allele in 705 obesity trios (nominal p = 0.009, OR = 1.23) and an increased frequency of the same allele in 359 cases compared to 429 controls (nominal p = 0.042, OR = 1.23). The obesity risk-alleles at Thr484Ala and βThr656Ile/γPro674Ser had no effect on STAT3 mediated leptin receptor signalling in splice variants β and γ.

conclusionThe rare coding mutation βThr656Ile/γPro674Ser (g.9483C/T) in SH2B1 was exclusively detected in overweight or obese individuals. Functional analyzes did not reveal impairments in leptin signalling for the mutated SH2B1.

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyAdaptor Proteins, Signal TransducingAdolescentAdultBinding SitesChildComputational BiologyDNA Mutational AnalysisFemaleGene FrequencyGlycosylationHumansLeptinLuciferasesMaleAdaptor Proteins, Signal TransducingLeptinLuciferasesReceptors, LeptinRNA Splice SitesSH2B1 protein, humanSTAT3 protein, humanSTAT3 Transcription FactorTranscription Factors

Identifiers

PMID23270367
PMCPMC3544595
OpenAlexW1999308712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.